Empresa Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Acciones
REKA
IL0010810096
Farmacéuticos
Resumen de negocios
Ventas por actividad
ILS en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Core Products
64,8
%
| 161 | 60,9 % | 190 | 64,8 % | +17,90 % |
Distribution Special
29,8
%
| 88 | 33,5 % | 87 | 29,8 % | -1,33 % |
Other
5,4
%
| 15 | 5,6 % | 16 | 5,4 % | +5,64 % |
Ventas por región
ILS en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 264 | 100,0 % | 292 | 100,0 % | +10,78 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 | |
Jack Azran
PRN | Corporate Officer/Principal | - | - |
Guy Zangi
SAM | Sales & Marketing | 51 | 13/09/18 |
Yuval Elgrably
PRN | Corporate Officer/Principal | 47 | 31/03/11 |
Ronit Zelnik
PRN | Corporate Officer/Principal | 66 | 09/01/97 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 15/06/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Chief Executive Officer | 80 | 24/08/93 | |
Director/Board Member | 78 | 24/08/93 | |
Orly Silberman
BRD | Director/Board Member | 64 | 15/04/15 |
Udi Nissan Nisan
BRD | Director/Board Member | 55 | 01/11/16 |
Arnon Zuaretz
BRD | Director/Board Member | 69 | 01/11/16 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 11 523 922 | 2 000 627 ( 17,36 %) | 19 900 ( 0,1727 %) | 17,36 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,35 % | 71,39 mil M | |
+2,39 % | 25,1 mil M | |
+5,38 % | 8590,68 M | |
+6,69 % | 8187,39 M | |
-20,96 % | 7914,57 M | |
+0,49 % | 4540,5 M | |
+17,12 % | 4313,82 M | |
-3,38 % | 3930,42 M | |
-2,61 % | 3859,77 M |